Catherine Handy Marshall, M.D., M.P.H.

Headshot of Catherine Handy Marshall
  • Assistant Professor of Oncology
Female

Expertise

Internal Medicine, Oncology

Research Interests

Advanced Prostate Cancer; Genomics of Prostate Cancer; Cancer and Cardiovascular Disease ...read more

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment

Locations

Skip Viragh Outpatient Cancer Center

Appointment Phone: 410-955-8964
201 N. Broadway
Baltimore, MD 21287
Phone: 410-955-8893
Skip Viragh Outpatient Cancer Center - Google Maps

Background

Dr. Catherine Marshall is an Assistant Professor in the Department of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine and oncology.

She received her M.D. and M.P.H. from Johns Hopkins, where she also completed her residency and an oncology fellowship. She previously served as an Assistant Chief of Service for the Osler Medical Housestaff Training Program.

...read more

Titles

  • Assistant Professor of Oncology

Departments / Divisions

  • Oncology - Genitourinary Cancer Disease

Education

Degrees

  • MD; Johns Hopkins University School of Medicine (2012)

Residencies

  • Internal Medicine; Johns Hopkins University School of Medicine (2015)

Fellowships

  • Oncology; Johns Hopkins University School of Medicine (2016)
  • Oncology; Johns Hopkins University School of Medicine (2019)

Board Certifications

  • American Board of Internal Medicine (Internal Medicine) (2015)
  • American Board of Internal Medicine (Oncology) (2018)

Research & Publications

Research Summary

Dr. Handy Marshall's research focuses on the relationship between cardiovascular disease and cancer, clinical trials in advanced prostate cancer, and genetics in prostate cancer.

Selected Publications

View all on PubMed

Marshall CH, Fu W, Wang H, Baras AS, Lotan TL, Antonarakis ES. Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage. Prostate Cancer Prostatic Dis. 2018 Aug 31. doi: 10.1038/s41391-018-0086-1. [Epub ahead of print] PubMed PMID: 30171229.

Handy CE, Quispe R, Pinto X, Blaha MJ, Blumenthal RS, Michos ED, Lima JAC, Guallar E, Ryu S, Cho J, Kaye JA, Comin-Colet J, Corbella X, Cainzos-Achirica M. Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment. Circulation. 2018 Aug 14;138(7):727-734. doi: 10.1161/CIRCULATIONAHA.118.035516. PubMed PMID: 30359131.

Handy CE, Antonarakis ES. Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions. Future Oncol. 2018 Apr;14(10):907-917. doi: 10.2217/fon-2017-0531. Epub 2017 Dec 20. Review. PubMed PMID: 29260582; PubMed Central PMCID: PMC5925432.

Handy CE, Antonarakis ES. Sequencing Treatment for Castration-Resistant Prostate Cancer. Curr Treat Options Oncol. 2016 Dec;17(12):64. Review. PubMed PMID: 27822685.

Handy Marshall C, Nahas-Vigon J, Manesh R, Gelber AC. Just Beneath the Surface. N Engl J Med. 2018 Sep 6;379(10):968-973. doi: 10.1056/NEJMcps1802664. PubMed PMID: 30184453.

Activities & Honors

Honors

  • Blumenthal Award, Johns Hopkins University School of Medicine, 2015
  • Young Investigator Award, Women Who Conquer Cancer, 2017
  • Award Recipient, Stuart Scott Memorial Cancer Research Fund V Foundation, 2021
  • Young Investigator Award, Prostate Cancer Foundation, 2021
Is this you? Edit Profile
back to top button